Bioactivity:

Amenamevir is a novel helicase-primase inhibitor that is active against varicella-zoster virus and herpes simplex virus types 1 and 2 (EC50: 14 ng/mL).

CAS nr:

841301-32-4

Purity:

98%

Molecular Weight:

482,56

SMILES:

Cc1c(c(ccc1)C)N(CC(=O)Nc1ccc(cc1)c1nocn1)C(=O)C1CCS(=O)(=O)CC1

Formula:

C24H26N4O5S

Pathway:

DNA Damage/DNA Repair,Cell Cycle/Checkpoint,Microbiology/Virology

Target:

DNA/RNA Synthesis,DNA/RNA Synthesis,HSV